Sanjiv.Parant.

{
  "main_header": {
    "sid": 328426,
    "name": "Sanjiv.Parant.",
    "stock_name": "Sanjiv.Parant.",
    "full_name": "Sanjivani Paranteral Ltd",
    "name_url": "stocks-analysis/sanjivparant",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "189.75",
    "chg": -5.15,
    "chgp": "-2.64%",
    "dir": -1,
    "prev_price": "194.90",
    "mcapval": "239.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531569,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE860D01013",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "2.23 k",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sanjivparant-328426-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sanjivani Paranteral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-sell-3824213",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SanjivaniParant_mojoScore_3824213.png",
        "date": "2026-02-06 10:10:03",
        "description": "Sanjivani Paranteral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "When is the next results date for Sanjivani Paranteral Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sanjivani-paranteral-ltd-3823075",
        "imagepath": "",
        "date": "2026-02-05 23:16:50",
        "description": "The next results date for Sanjivani Paranteral Ltd is scheduled for 13 February 2026...."
      },
      {
        "title": "Sanjivani Paranteral Ltd Falls to 52-Week Low of Rs.161 Amid Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-falls-to-52-week-low-of-rs161-amid-market-underperformance-3818805",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SanjivaniParant_priceRelatedfactors_3818805.png",
        "date": "2026-02-03 16:12:30",
        "description": "Sanjivani Paranteral Ltd’s shares declined sharply to a fresh 52-week low of Rs.161 on 3 February 2026, marking a significant downturn amid a broader market rally. The stock has underperformed its sector and the wider market, reflecting a series of financial and valuation concerns that have weighed on investor sentiment."
      },
      {
        "title": "Sanjivani Paranteral Ltd Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-falls-to-52-week-low-amidst-continued-downtrend-3816444",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SanjivaniParant_priceRelatedfactors_3816444.png",
        "date": "2026-02-02 11:18:20",
        "description": "Sanjivani Paranteral Ltd’s shares declined sharply to a fresh 52-week low of Rs.162.1 on 2 Feb 2026, marking a significant downturn amid broader market pressures and company-specific performance factors. The stock has now recorded a three-day consecutive fall, cumulatively losing 4.74% over this period, underperforming its sector and the broader market indices."
      },
      {
        "title": "Sanjivani Paranteral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-sell-3804701",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SanjivaniParant_mojoScore_3804701.png",
        "date": "2026-01-26 10:10:05",
        "description": "Sanjivani Paranteral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 January 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Sanjivani Paranteral Ltd Stock Falls to 52-Week Low of Rs.169",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-stock-falls-to-52-week-low-of-rs169-3798576",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SanjivaniParant_priceRelatedfactors_3798576.png",
        "date": "2026-01-21 11:40:14",
        "description": "Sanjivani Paranteral Ltd’s shares declined to a fresh 52-week low of Rs.169 on 21 Jan 2026, marking a significant downturn amid broader market weakness and company-specific performance pressures. The stock has underperformed its sector and the broader market, reflecting a challenging period for the pharmaceuticals and biotechnology firm."
      },
      {
        "title": "Sanjivani Paranteral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-sell-3792784",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SanjivaniParant_mojoScore_3792784.png",
        "date": "2026-01-15 10:10:27",
        "description": "Sanjivani Paranteral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 January 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Sanjivani Paranteral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-sell-3780554",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SanjivaniParant_mojoScore_3780554.png",
        "date": "2026-01-04 10:10:04",
        "description": "Sanjivani Paranteral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 January 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing."
      },
      {
        "title": "Why is Sanjivani Paranteral Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sanjivani-paranteral-ltd-fallingrising-3779243",
        "imagepath": "",
        "date": "2026-01-03 01:38:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Daily Performance and Market Outperformance</strong></p>\n<p>The stock opened with a gap up, immediately gaining 2.89% at the start of trading, signalling strong buying interest from the outset. Throughout the day, it maintained this momentum, touching an intraday high of ₹235. This performance notably outperformed its sector by 2.3%, indicating that investors are favouring Sanjivani Paranteral relative to its peers in the pharmaceutical and biotechnology space.</p>\n<p>Such outperformance is significant given the broader market context, where the Sensex showed a modest gain of 0.64% year-to-date and 0.73% over the past month. Sanjivani Paranteral’s one-month return of 18.21% far exceeds the benchmark, highlighting a strong recovery and investor confidence in the company’s prospects.</p..."
      }
    ],
    "total": 191,
    "sid": "328426",
    "stock_news_url": "https://www.marketsmojo.com/news/sanjivani-paranteral-328426"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Friday 13Th February 2026 Pursuant To Regulation 29(1)(A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "04-Feb-2026",
      "details": "Sanjivani Paranteral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve This is to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 13th February 2026 at the registered office of the Company to consider and transact the following businesses: 1. To approve the Un-Audited Financials along with Limited Review Report for the Third Quarter ended 31st December 2025 pursuant to Regulation 33 of the Listing Obligation and Disclosure Requirement 2015. 2. Any other matter with the permission of Chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. The approved results will be sent to you after conclusion of the Board meeting. Kindly take the same on your record and acknowledge the receipt.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Jan-2026",
      "details": "Certificate under regulation 74(5) for the Quarter ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Dec-2025",
      "details": "Closure of Trading Window for the Quarter ended 31st December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sanjivani Paranteral Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sanjivani Paranteral Ltd is Rated Sell

2026-02-06 10:10:03

Sanjivani Paranteral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

When is the next results date for Sanjivani Paranteral Ltd?

2026-02-05 23:16:50

The next results date for Sanjivani Paranteral Ltd is scheduled for 13 February 2026....

Read full news article

Sanjivani Paranteral Ltd Falls to 52-Week Low of Rs.161 Amid Market Underperformance

2026-02-03 16:12:30

Sanjivani Paranteral Ltd’s shares declined sharply to a fresh 52-week low of Rs.161 on 3 February 2026, marking a significant downturn amid a broader market rally. The stock has underperformed its sector and the wider market, reflecting a series of financial and valuation concerns that have weighed on investor sentiment.

Read full news article

Sanjivani Paranteral Ltd Falls to 52-Week Low Amidst Continued Downtrend

2026-02-02 11:18:20

Sanjivani Paranteral Ltd’s shares declined sharply to a fresh 52-week low of Rs.162.1 on 2 Feb 2026, marking a significant downturn amid broader market pressures and company-specific performance factors. The stock has now recorded a three-day consecutive fall, cumulatively losing 4.74% over this period, underperforming its sector and the broader market indices.

Read full news article

Sanjivani Paranteral Ltd is Rated Sell

2026-01-26 10:10:05

Sanjivani Paranteral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Sanjivani Paranteral Ltd Stock Falls to 52-Week Low of Rs.169

2026-01-21 11:40:14

Sanjivani Paranteral Ltd’s shares declined to a fresh 52-week low of Rs.169 on 21 Jan 2026, marking a significant downturn amid broader market weakness and company-specific performance pressures. The stock has underperformed its sector and the broader market, reflecting a challenging period for the pharmaceuticals and biotechnology firm.

Read full news article

Sanjivani Paranteral Ltd is Rated Sell

2026-01-15 10:10:27

Sanjivani Paranteral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Sanjivani Paranteral Ltd is Rated Sell

2026-01-04 10:10:04

Sanjivani Paranteral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 January 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing.

Read full news article

Why is Sanjivani Paranteral Ltd falling/rising?

2026-01-03 01:38:03

Strong Daily Performance and Market Outperformance

The stock opened with a gap up, immediately gaining 2.89% at the start of trading, signalling strong buying interest from the outset. Throughout the day, it maintained this momentum, touching an intraday high of ₹235. This performance notably outperformed its sector by 2.3%, indicating that investors are favouring Sanjivani Paranteral relative to its peers in the pharmaceutical and biotechnology space.

Such outperformance is significant given the broader market context, where the Sensex showed a modest gain of 0.64% year-to-date and 0.73% over the past month. Sanjivani Paranteral’s one-month return of 18.21% far exceeds the benchmark, highlighting a strong recovery and investor confidence in the company’s prospects.Read full news article

View All News